تفاعل #2146687

ord-9479d13a8d1746ebbe026f8062d709fe

معادلة التفاعل

O
water
COc1ccc2nc(-c3ccc(O)cc3)cn2c1
2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine
O=C([O-])[O-].[K+].[K+]
potassium carbonate
FCCCBr
1-bromo-3-fluoropropane
COc1ccc2nc(-c3ccc(OCCCF)cc3)cn2c1
2-[4′-(3″-fluoropropoxy)phenyl]-6-methoxyimidazo[1,2-a]pyridine
المردود 63.0%

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    أخرىto remove moisture
  2. 2
    workup.DISSOLUTIONwas dissolved in 10 L of N,N-dimethylformamide
  3. 3
    أخرىAfter the completion of the reaction
  4. 4
    استخلاصextracted three times with chloroform
  5. 5
    غسيلThe combined chloroform layer was washed once with water and once with a saturated sodium chloride solution
  6. 6
    تجفيفdried over anhydrous sodium sulfate
  7. 7
    ترشيحfiltered
  8. 8
    تركيزconcentrated
  9. 9
    أخرىThe resulting crude product was purified by recycle preparative HPLC (HPLC apparatus

الإجراء التجريبي

242 mg (corresponding to 1.0 mmol) of 2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine that was sufficiently dried to remove moisture was dissolved in 10 L of N,N-dimethylformamide, and 418 mg (corresponding to 3.0 mmol) of potassium carbonate was added thereto. The mixture was supplemented with 140 μL (corresponding to 1.5 mmol) of 1-bromo-3-fluoropropane, and then was stirred at room temperature for 18 hours. After the completion of the reaction, the reaction solution was poured into water and extracted three times with chloroform. The combined chloroform layer was washed once with water and once with a saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated. The resulting crude product was purified by recycle preparative HPLC (HPLC apparatus: LC-908 (under trade name: manufactured by Japan Analytical Industry Co., Ltd.); column: two JAIGEL 2H (under trade name; manufactured by Japan Analytical Industry Co., Ltd.) connected together; mobile phase: chloroform), to obtain 189 mg (corresponding to 0.63 mmol) of 2-[4′-(3″-fluoropropoxy)phenyl]-6-methoxyimidazo[1,2-a]pyridine (hereinafter referred to as Compound 1) (FIG. 2, Step 6).

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08277777B2uspto-grants-2012_10